These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 22057374

  • 1. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels.
    Ahn HS, Kim YS, Kim SG, Kim HK, Min SK, Jeong SW, Jang JY, Lee SH, Kim HS, Kim BS, Park JM.
    Hepatogastroenterology; 2012 Jun; 59(116):1168-73. PubMed ID: 22057374
    [Abstract] [Full Text] [Related]

  • 2. Serum cystatin C in advanced liver cirrhosis and different stages of the hepatorenal syndrome.
    Barakat M, Khalil M.
    Arab J Gastroenterol; 2011 Sep; 12(3):131-5. PubMed ID: 22055590
    [Abstract] [Full Text] [Related]

  • 3. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels.
    Seo YS, Jung ES, An H, Kim JH, Jung YK, Kim JH, Yim HJ, Yeon JE, Byun KS, Kim CD, Ryu HS, Um SH.
    Liver Int; 2009 Nov; 29(10):1521-7. PubMed ID: 19725889
    [Abstract] [Full Text] [Related]

  • 4. Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?
    Finkenstedt A, Dorn L, Edlinger M, Prokop W, Risch L, Griesmacher A, Graziadei I, Vogel W, Zoller H.
    Liver Int; 2012 Sep; 32(8):1211-6. PubMed ID: 22380485
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome.
    Demirtaş S, Bozbaş A, Akbay A, Yavuz Y, Karaca L.
    Clin Chim Acta; 2001 Sep 25; 311(2):81-9. PubMed ID: 11566167
    [Abstract] [Full Text] [Related]

  • 6. Plasma cystatin C as a marker of renal function in patients with liver cirrhosis.
    Randers E, Ivarsen P, Erlandsen EJ, Hansen EF, Aagaard NK, Bendtsen F, Vilstrup H.
    Scand J Clin Lab Invest; 2002 Sep 25; 62(2):129-34. PubMed ID: 12004928
    [Abstract] [Full Text] [Related]

  • 7. Serum cystatin C: a non-invasive marker of liver fibrosis or of current liver fibrogenesis in chronic hepatitis C? .
    Ladero JM, Cárdenas MC, Ortega L, González-Pino A, Cuenca F, Morales C, Lee-Brunner A.
    Ann Hepatol; 2012 Sep 25; 11(5):648-51. PubMed ID: 22947524
    [Abstract] [Full Text] [Related]

  • 8. Assessment and prediction of acute kidney injury in patients with decompensated cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase.
    Kim TH, Lee HA, Seo YS, Lee YR, Yim SY, Lee YS, Suh SJ, Jung YK, Kim JH, An H, Yim HJ, Yeon JE, Byun KS, Um SH, Korean Study Group of Portal Hypertension.
    J Gastroenterol Hepatol; 2019 Jan 25; 34(1):234-240. PubMed ID: 30062791
    [Abstract] [Full Text] [Related]

  • 9. Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly.
    Bevc S, Hojs R, Ekart R, Gorenjak M, Puklavec L.
    Ther Apher Dial; 2011 Jun 25; 15(3):261-8. PubMed ID: 21624073
    [Abstract] [Full Text] [Related]

  • 10. Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites.
    Seo YS, Park SY, Kim MY, Kim SG, Park JY, Yim HJ, Jang BK, Park SH, Kim JH, Suk KT, Kim JD, Kim TY, Cho EY, Lee JS, Jung SW, Jang JY, An H, Tak WY, Baik SK, Hwang JS, Kim YS, Sohn JH, Um SH.
    J Gastroenterol Hepatol; 2018 Apr 25; 33(4):910-917. PubMed ID: 28910501
    [Abstract] [Full Text] [Related]

  • 11. Kidney function estimating equations in patients with chronic kidney disease.
    Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L.
    Int J Clin Pract; 2011 Apr 25; 65(4):458-64. PubMed ID: 21401834
    [Abstract] [Full Text] [Related]

  • 12. Serum cystatin C in elderly cardiac surgery patients.
    Ristikankare A, Pöyhiä R, Kuitunen A, Skrifvars M, Hämmäinen P, Salmenperä M, Suojaranta-Ylinen R.
    Ann Thorac Surg; 2010 Mar 25; 89(3):689-94. PubMed ID: 20172110
    [Abstract] [Full Text] [Related]

  • 13. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation.
    Samyn M, Cheeseman P, Bevis L, Taylor R, Samaroo B, Buxton-Thomas M, Heaton N, Rela M, Mieli-Vergani G, Dhawan A.
    Liver Transpl; 2005 Mar 25; 11(3):344-9. PubMed ID: 15719405
    [Abstract] [Full Text] [Related]

  • 14. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Mar 25; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of glomerular filtration rate in children--serum markers and prediction equations].
    Nakai K, Kikuchi M, Koyamaa T, Saito K, Suwabe A.
    Rinsho Byori; 2009 Apr 25; 57(4):338-44. PubMed ID: 19489435
    [Abstract] [Full Text] [Related]

  • 16. Cystatin C, a novel measure of renal function, is an independent predictor of cardiac events in patients with heart failure.
    Arimoto T, Takeishi Y, Niizeki T, Takabatake N, Okuyama H, Fukui A, Tachibana H, Nozaki N, Hirono O, Tsunoda Y, Miyashita T, Shishido T, Takahashi H, Koyama Y, Kubota I.
    J Card Fail; 2005 Oct 25; 11(8):595-601. PubMed ID: 16230262
    [Abstract] [Full Text] [Related]

  • 17. The inaccuracy of cystatin C and creatinine-based equations in predicting GFR in orthotopic liver transplant recipients.
    Boudville N, Salama M, Jeffrey GP, Ferrari P.
    Nephrol Dial Transplant; 2009 Sep 25; 24(9):2926-30. PubMed ID: 19506046
    [Abstract] [Full Text] [Related]

  • 18. Serum cystatin C is related to pulse wave velocity even in subjects with normal serum creatinine.
    Song SH, Kwak IS, Kim YJ, Lee HS, Rhee H, Lee DW, Kang YH, Kim SJ.
    Hypertens Res; 2008 Oct 25; 31(10):1895-902. PubMed ID: 19015597
    [Abstract] [Full Text] [Related]

  • 19. [Usefulness of the formula for predicting creatinine clearance from serum cystatin C].
    Oyabu C, Hayashi N, Sugiyama D, Umezu M, Kinoshita S, Hayashi H, Kawano S, Kumagai S.
    Rinsho Byori; 2008 Dec 25; 56(12):1093-9. PubMed ID: 19175073
    [Abstract] [Full Text] [Related]

  • 20. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG, Grubb AO, Nilsson JA, Norrgren K, Sterner G, Sundkvist G.
    J Intern Med; 2004 Dec 25; 256(6):510-8. PubMed ID: 15554952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.